과제정보
본 증례를 발표할 수 있도록 자료의 사용을 허락해 준 환자에게 감사드린다.
참고문헌
- Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646-50. https://doi.org/10.1016/0002-9343(93)90218-E
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.
- Mauck KF, Clarke BL. Diagnosis, screening, prevention, and treatment of osteoporosis. Mayo Clin Proc. 2006;81(5):662-72. https://doi.org/10.4065/81.5.662
- Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B. Mortality after osteoporotic fractures. Osteoporos Int. 2004 Jan;15(1):38-42. https://doi.org/10.1007/s00198-003-1490-4
- Ha YC, Kim TY, Lee A, Lee YK, Kim HY, Kim JH, et al. Current trends and future projections of hip fracture in South Korea using nationwide claims data. Osteoporos Int. 2016;27(8):2603-9. https://doi.org/10.1007/s00198-016-3576-9
- Kim J, Lee E, Kim S, Lee TJ. Economic Burden of Osteoporotic Fracture of the Elderly in South Korea: A National Survey. Value Health Reg Issues. 2016;9:36-41. https://doi.org/10.1016/j.vhri.2015.09.007
- Kanis J. Assessment of osteoporosis at the primary health-care level. Technical Report: WHO Collaborating Centre, University of Sheffield; 2008 [cited Nov 2020]. Available from: http://www.shef.ac.uk/FRAX
- Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-81. https://doi.org/10.1007/s00198-014-2794-2
- Mikyas Y, Agodoa I, Yurgin N. A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men. Appl Health Econ Health Policy. 2014;12(3):267-77. https://doi.org/10.1007/s40258-013-0078-1
- Zhao JG, Zeng XT, Wang J, Liu L. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017;318(24):2466-82. https://doi.org/10.1001/jama.2017.19344
- Liu Y, Liu JP, Xia Y. Chinese herbal medicines for treating osteoporosis. Cochrane Database Syst Rev. 2014;(3):CD005467.
- Yun G, Kang J, Lee H. Effects of Korean herbal medicine (Cheong-A-Won) for treatment of bone mineral density in women with osteoporosis: A randomized, double blind, placebo controlled trial. Eur J Integr Med. 2018;20:84-9. https://doi.org/10.1016/j.eujim.2018.04.009
- Guide publishing group of Korean society for bone and mineral research. Physician's guide for osteoporosis. Seoul: Cdmthebig 2018.
- Department of kidney internal medicine. Kidney Internal Medicine. Seoul: Gunjachulpansa 2015:116-20.
- Lee H, Hahm D, Kim H, Sohn B, Hwang D, Choi Y, editors. The effect of Jeopgol-tang on recovery of bone fracture in Sprague-Dawley rats. The Annual Conference of Traditional Korean Medicine 2006.
- Lee H, Hahm D, Kim H, Sohn B, Choi Y, DS H. Crude drugs composition for accelerating recovery of bone fracture. 10-0731160. 2007.
- Leutner M, Matzhold C, Bellach L, Deischinger C, Harreiter J, Thurner S, et al. Diagnosis of osteoporosis in statin-treated patients is dose-dependent. Ann Rheum Dis. 2019;78(12):1706-11. https://doi.org/10.1136/annrheumdis-2019-215714
- Hong S, You S. A study of prevalence and related risk factors of osteoporosis for employees. JKIECS 2013;8(4):631-7.
- Han G, Kim S. What Cases Are Worth Publishing in the Korean Medical Case Report? Korean J Acupunct 2020;37(3):159-71. https://doi.org/10.14406/acu.2020.021
- Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. https://doi.org/10.1186/1752-1947-7-223
- Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clinic proceedings. 2002;77(5):453-68. https://doi.org/10.4065/77.5.453